Jointly awarded by the Columbia Precision Medicine Initiative (CPMI), the Herbert Irving Comprehensive Cancer Center (HICCC), and the Irving Institute for Clinical and Translational Research, the Precision Medicine Pilot Grants underscore Columbia University’s commitment to supporting diverse, cross-disciplinary research targeting the promise of precision medicine. Four teams will receive a one-year $100,000 grant to support their research. One of the projects is being led by DSB principal investigator Chaolin Zhang, PhD along with Harris Wang, PhD.

Read full article on the Precision Medicine news page.